Publikationen von M. B. Müller

Singewald, N.; Nguyen, N. K.; Hetzenauer, A.; Thöringer, C. K.; Wurst, W.; Deussing, J.; Müller, M. B.; Holsboer, F.; Keck, M. E.: Conditional Crh1 receptor knockout mice show altered neuronal activation pattern to mild anxiogenic challenge. Journal of Neurochemistry 94 (Suppl. 2), S. 230 - 230 (2005)

Refojo, D.; Echenique, C.; Müller, M. B.; Reul, J. M. H. M.; Deussing, J. M.; Wurst, W.; Sillaber, I.; Paez-Pereda, M.; Holsboer, F.; Arzt, E.: Corticotropin-releasing hormone activates ERK1/2 MAPK in specific brain areas. Proceedings of the National Academy of Sciences of the United States of America 102 (17), S. 6183 - 6188 (2005)

Keck, M. E.; Sartori, S. B.; Welt, T.; Müller, M. B.; Ohl, F.; Holsboer, F.; Landgraf, R.; Singewald, N.: Differences in serotonergic neurotransmission between rats displaying high or low anxiety/depression-like behaviour: effects of chronic paroxetine treatment. Journal of Neurochemistry 92 (5), S. 1170 - 1179 (2005)

Schmidt, M.; Levine, S.; Oitzl, M. S.; van der Mark, M.; Müller, M. B.; Holsboer, F.; de Kloet, E. R.: Glucocorticoid receptor blockade disinhibits pituitary-adrenal activity during the stress hyporesponsive period of the mouse. Endocrinology 146 (3), S. 1458 - 1464 (2005)

Keck, M. E.; Ohl, F.; Holsboer, F.; Müller, M. B.: Listening to mutant mice: a spotlight on the role of CRF/CRF receptor systems in affective disorders. Neuroscience and Biobehavioral Reviews 29 (4-5 Sp. Iss.), S. 867 - 889 (2005)

Schmidt, M. V.; Oitzl, M. S.; Müller, M. B.; Ohl, F.; Wurst, W.; Holsboer, F.; Levine, S.; De Kloet, E. R.: Regulation of the developing hypothalamic-pituitary-adrenal axis in corticotropin releasing hormone receptor 1-deficient mice (vol 119, pg 589, 2003). Neuroscience 135 (4), S. 1343 - 1343 (2005)

Erhardt, A.; Sillaber, I.; Welt, T.; Müller, M. B.; Singewald, N.; Keck, M. E.: Repetitive transcranial magnetic stimulation increases the release of dopamine in the nucleus accumbens shell of morphine-sensitized rats during abstinence. Neuropsychopharmacology 29 (11), S. 2074 - 2080 (2004)

Woessner, R.; Grauer, M.; Bianchi, O.; Mueller, M.; Moersdorf, S.; Berlit, P.; Goertler, M.; Grotemeyer, K. H.; Sliwka, U.; Stoll, M. et al.; Treib, J.: Treatment with anticoagulants in cerebral events (TRACE). Thrombosis and Haemostasis 91 (4), S. 690 - 693 (2004)

Müller, M. B.; Zimmermann, S.; Sillaber, I.; Hagemeyer, T. P.; Deussing, J. M.; Droste, S.; Reul, J. H. M. H.; Holsboer, F.; Wurst, W.: Limbic Crhr1 mediates anxiety-related behaviour and is required for hormonal adaptation to stress. European Neuropsychopharmacology 14 (Suppl. 1), S. S27 - S28 (2004)

Müller, M. B.; Uhr, M.; Holsboer, F.; Keck, M. E.: Hypothalamic-pituitary-adrenocortical system and mood disorders: Highlights from mutant mice. Neuroendocrinology 79 (1), S. 1 - 12 (2004)

Müller, M. B.; Wurst, W.: Getting closer to affective disorders: the role of CRH receptor systems. Trends in Molecular Medicine 10 (8), S. 409 - 415 (2004)

Greetfeld, M.; Müller, M. B.: Analysis of stress-induced CRH, CRHR1, AVP and mineralocorticoid receptor (MR) mRNA expression in C57/Bl6 mice: Implications for HPA-system regulation. Pharmacopsychiatry 36 (5), S. 229 - 229 (2003)

Keck, M. E.; Welt, T.; Müller, M. B.; Landgraf, R.; Holsboer, F.: Modulation of CRH and AVP as a therapeutic strategy in anxiety disorders. Pharmacopsychiatry 36 (5), S. 239 - 239 (2003)

Müller, M. B.; Zimmermann, S.; Sillaber, I.; Hagemeyer, T. P.; Deussing, J.; Droste, S.; Reul, J. H. M. H.; Holsboer, F.; Wurst, W.: Limbic Crhr1 mediates anxiety-related behaviour and is required for hormonal adaptation to stress. Pharmacopsychiatry 36 (5), S. 249 - 249 (2003)

Droste, S. K.; Gesing, A.; Ulbricht, S.; Müller, M. B.; Linthorst, A. C. E.; Reul, J. M. H. M.: Effects of long-term voluntary exercise on the mouse hypothalamic-pituitary-adrenocortical axis. Endocrinology 144 (7), S. 3012 - 3023 (2003)

Keck, M. E.; Welt, T.; Müller, M. B.; Uhr, M.; Ohl, F.; Wigger, A.; Toschi, N.; Holsboer, F.; Landgraf, R.: Reduction of hypothalamic vasopressinergic hyperdrive contributes to clinically relevate behavioral and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat model. Neuropsychopharmacology 28 (2), S. 235 - 243 (2003)

Keck, M. E.; Welt, T.; Erhardt, A.; Müller, M. B.; Sillaber, I.: Neuroendokrine Effekte der repetitiven transkraniellen Magnetstimulation. Fokus auf Dopamin und Vasopressin. Nervenheilkunde 22 (7), S. 346 - 349 (2003)

Keck, M. E.; Welt, T.; Müller, M. B.; Landgraf, R.; Holsboer, F.: The high-affinity non-peptide CRH1 receptor antagonist R121919 attenuates stress-induced alterations in plasma oxytocin, prolactin, and testosterone secretion in rats. Pharmacopsychiatry 36 (1), S. 27 - 31 (2003)

Müller, M. B.; Keck, M. E.; Binder, E. B.; Kresse, A. E.; Hagemeyer, T. P.; Landgraf, R.; Holsboer, F.; Uhr, M.: ABCBI (MDRI)- type P-Glycoproteins at the blood-brain barrier modulate the activity of the hypothalamic-pituitary-adrenocortical system: implications for affective disorder. Neuropsychopharmacology 28 (11), S. 1991 - 1999 (2003)

Müller, M. B.; Zimmermann, S.; Sillaber, I.; Hagemeyer, T. P.; Deussing, J. M.; Timpl, P.; Kormann, M. S. D.; Droste, S. K.; Kühn, R.; Reul, J. M. H. M. et al.; Holsboer, F.; Wurst, W.: Limbic corticotropin-releasing hormone receptor I mediates anxiety-related behavior and hormonal adaptation to stress. Nature Neuroscience 6 (10), S. 1100 - 1107 (2003)